Herbalife Nutrition Ltd (NYSE: HLF)

Herbalife Nutrition Ltd. develops and sells nutrition solutions in North America, Mexico, South and Central America, Europe, the Middle East, Africa, and the Asia Pacific. It provides science-based products in the areas of weight management; targeted nutrition; energy, sports, and fitness; and outer nutrition.

Take a look at the 1-year chart of Herbalife (NYSE: HLF) below with added notations:

HLF has stalled at the same $60 resistance area (red) twice over the past six months. The stock has recently turned higher, and now is sitting just a few percentage points below that $60 level. A solid close above the resistance should lead to another leg higher for HLF.

Continue Reading »

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY)

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapeutics based on RNA interference (RNAi). Its pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, and hepatic infectious diseases.

Take a look at the 1-year chart of Alnylam (NASDAQ: ALNY) below with my added notations:

During the past several months, ALNY has formed an important level of resistance to watch at the $90 (blue) mark, a level that was also prior support. The stock tested that $90 mark again last week. A close above that $90 level should lead to higher prices.

Continue Reading »

Axalta Coating Systems Ltd (NYSE: AXTA)

Axalta Coating Systems Ltd., through its subsidiaries, manufactures, markets, and distributes high performance coatings primarily for the transportation industry. It operates in two segments, Performance Coatings and Transportation Coatings.

Take a look at the 1-year chart of Axalta (NYSE: AXTA) with the added notations:

AXTA formed a key level of support at $24 (green) back towards the end of last year, and after breaking below that mark, the stock has rallied back above it. If AXTA comes back down to that $24 level again, traders should be able to expect some sort of a bounce. However, if the $24 support were to break, lower prices should follow for the stock.

Continue Reading »

Intercept Pharmaceuticals (NASDAQ: ICPT)

Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics in the United States, Europe, and Canada. Its lead product candidate is obeticholic acid (OCA), a bile acid analog, which has a structure based on a naturally occurring human bile acid that selectively binds to and activates the farnesoid X receptor (FXR).

Take a look at the 1-year chart of Intercept (NASDAQ: ICPT) below with my added notations:

During the past couple of months, ICPT has formed an important level of resistance to watch at the $115 (red) mark. The stock almost tested that mark again last week. A close above that $115 level could mean a run up to the previous high, at minimum.

Continue Reading »

ABIOMED, Inc. (NASDAQ: ABMD)

ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides continuum of care to heart failure patients.

Take a look at the 1-year chart of Abiomed (NASDAQ: ABMD) below with added notations:

After declining from its October peak, ABMD has now moved into a sideways trading range. While in the range, the stock has formed a key resistance level at $340 (red), and a $280 support (green). At some point the stock will have to break one of the two levels.

Continue Reading »